Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Lower dose version of Caverject introduced

Oct. 23, 1997

Viagra awarded priority review status by FDA

Oct. 23, 1997

Role of angiotensin II in erectile function investigated

Oct. 23, 1997

Trazodone evaluated in patients with erectile dysfunction

Oct. 23, 1997

rhIGF-1 improves lipid profiles in adults with IDDM

Oct. 23, 1997

Ligand and Lilly enter drug discovery and development alliance for metabolic drugs

Oct. 23, 1997

Endocrinologic and Metabolic Drugs Advisory Committee meets in late November

Oct. 22, 1997

Mechanism of cytoprotective effects of bimoclomol

Oct. 22, 1997

Identification of metabolites of Sch-48461 leads to potent cholesterol absorption inhibitor

Oct. 22, 1997

Romozin now available in U.K.

Oct. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...